Literature DB >> 11854788

Bacteria--Mast Cell Interactions in Inflammatory Disease.

Ravi Malaviya1, Teruo Ikeda, Elaine A. Ross, Barbara A. Jakschik, Soman N. Abraham.   

Abstract

Chronic inflammatory diseases of the gastrointestinal tract such as ulcerative colitis and Crohn's disease are characterized by mast cell proliferation and secretion of inflammatory mediators. The determinant(s) responsible for stimulating mast cells in the intestinal mucosa is not known. We investigated the interaction of mast cells with type 1 fimbriated Escherichia coli, an opportunistic pathogen and a constituent of the normal indigenous microflora of the gut. Unlike a mutant derivative deficient in the FimH subunit of the fimbriae or nonfimbriated E. coli, type 1 fimbriated E. coli adhered avidly to mast cells. As a consequence of this interaction, the mast cells phagocytozed and killed adherent bacteria. The mast cell bactericidal activity involved generation of superoxide anion and acidification of phagocytic vacuoles. In addition, many of the mast cells had degranulated and released inflammatory mediators such as histamine. These observations have implications both for normal host defense and for the initiation and perpetuation of inappropriate inflammatory responses in the gastrointestinal tract.

Entities:  

Year:  1995        PMID: 11854788     DOI: 10.1097/00045391-199510000-00010

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  8 in total

1.  Mast cells kill Candida albicans in the extracellular environment but spare ingested fungi from death.

Authors:  Elisa Trevisan; Francesca Vita; Nevenka Medic; Maria Rosa Soranzo; Giuliano Zabucchi; Violetta Borelli
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

2.  NOD1 and NOD2 Interact with the Phagosome Cargo in Mast Cells: A Detailed Morphological Evidence.

Authors:  Giuliano Zabucchi; Elisa Trevisan; Francesca Vita; Maria Rosa Soranzo; Violetta Borelli
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

3.  Persistence of mucosal mast cells and eosinophils in Shigella-infected children.

Authors:  Rubhana Raqib; Pricila Khan Moly; Protim Sarker; Firdausi Qadri; Nurul Haque Alam; Minnie Mathan; Jan Andersson
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Integrated regulatory responses of fimB to N-acetylneuraminic (sialic) acid and GlcNAc in Escherichia coli K-12.

Authors:  Baljinder K Sohanpal; Sammia El-Labany; Maryam Lahooti; Jacqueline A Plumbridge; Ian C Blomfield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

5.  Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.

Authors:  Qian Liu; Xin Du; Xufen Hong; Tianming Li; Bing Zheng; Lei He; Yanan Wang; Michael Otto; Min Li
Journal:  Infect Immun       Date:  2015-03-16       Impact factor: 3.441

6.  Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.

Authors:  Anna Di Nardo; Kenshi Yamasaki; Robert A Dorschner; Yuping Lai; Richard L Gallo
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 7.  Mouse models for the study of colon carcinogenesis.

Authors:  Daniel W Rosenberg; Charles Giardina; Takuji Tanaka
Journal:  Carcinogenesis       Date:  2008-11-26       Impact factor: 4.944

8.  Colorectal carcinogenesis: Review of human and experimental animal studies.

Authors:  Takuji Tanaka
Journal:  J Carcinog       Date:  2009
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.